GWave
Tel Aviv
About GWave
Hagar is the developer of GWave, a non-invasive continuous glucose monitoring technology solution that uses RF waves to measure glucose levels in the blood continuously.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $21.1M
- Funding stage: Late Stage Venture
- Last round: Series C (Aug 2023)
- Website: hagartech.com
Industries & Categories
Health Care, Medical Device, RFID
Canonical: https://fsome.com/organization/gwave-125075 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.